Literature DB >> 21764465

Pierre Robin sequence: an institutional experience in the multidisciplinary management of airway, feeding and serous otitis media challenges.

F Glynn1, D Fitzgerald, M J Earley, H Rowley.   

Abstract

OBJECTIVES: To evaluate the course and prognosis of airway obstruction, feeding difficulties and hearing abnormalities in patients with Pierre Robin sequence (PRS).
METHODS: A retrospective review was conducted, of 69 patients with PRS, attending between 1991 and 2010 at the Children's University Hospital in Dublin. Data regarding airway management, nutritional status and hearing difficulties was collected prospectively.
RESULTS: Airway obstruction requiring intervention other than positional therapy was seen in 39% (27) patients. Fifty nine percent (16/27) of these patients, who failed positional therapy, were successfully managed with a nasopharyngeal airway. Following failed intervention with nasopharyngeal airways, two patients had airway maintenance achieved with a successful glossopexy procedure. One patient had an adequate airway achieved with nasal continuous positive airway pressure. Eight patients (12%) required a surgical tracheostomy. Of those who required a tracheostomy, six patients had isolated PRS, one patient had PRS in association with Stickler syndrome and one patient had Nager acro-facial dystosis. Duration of tracheostomy tube ranged from 10 to 19 months, mean 13 months. Seventy percent (48 patients) required supplementary feeding in the form of nasogastric (NG) or gastrostomy tube. Forty-four patients were successfully managed with a temporary NG tube. One patient required a prolonged NG tube, and three required a gastrostomy tube. Twenty-one (30%) patients were successfully managed with a specialised Haberman bottle. Twenty-four patients (35%) who had their airway managed successfully by positional therapy, still required supplemental feeding. Thirty-one patients (45%) demonstrated a conductive hearing loss at some stage, which affected their speech and language development. Twenty-four patients (35%) required tympanostomy tube insertion once, while 7 (10%) of patients required ventilation tube insertion twice or more.
CONCLUSION: Airway management in the majority of PRS can be successfully achieved by conservative methods. Even in the presence of an adequate airway, many patients will require supplemental feeding. Early audiological assessment is necessary as many patients will need tympanostomy tube placement to ensure adequate speech and language development.
Copyright © 2011. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21764465     DOI: 10.1016/j.ijporl.2011.06.009

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  12 in total

1.  Surgical versus nonsurgical interventions to relieve upper airway obstruction in children with Pierre Robin sequence.

Authors:  Karen Kam; Meghan McKay; Joanna MacLean; Manisha Witmans; Sheldon Spier; Ian Mitchell
Journal:  Can Respir J       Date:  2015-04-07       Impact factor: 2.409

2.  Longitudinal Sleep Outcomes in Neonates With Pierre Robin Sequence Treated Conservatively.

Authors:  Zarmina Ehsan; Christopher Kurian; K Nicole Weaver; Brian S Pan; Guixia Huang; Md M Hossain; Narong Simakajornboon
Journal:  J Clin Sleep Med       Date:  2019-03-15       Impact factor: 4.062

Review 3.  Surgical Management and Outcomes of Pierre Robin Sequence: A Comparison of Mandibular Distraction Osteogenesis and Tongue-Lip Adhesion.

Authors:  Rosaline S Zhang; Ian C Hoppe; Jesse A Taylor; Scott P Bartlett
Journal:  Plast Reconstr Surg       Date:  2018-08       Impact factor: 4.730

Review 4.  Microdeletion del(22)(q12.2) encompassing the facial development-associated gene, MN1 (meningioma 1) in a child with Pierre-Robin sequence (including cleft palate) and neurofibromatosis 2 (NF2): a case report and review of the literature.

Authors:  Tom B Davidson; Pedro A Sanchez-Lara; Linda M Randolph; Mark D Krieger; Shi-Qi Wu; Ashok Panigrahy; Hiroyuki Shimada; Anat Erdreich-Epstein
Journal:  BMC Med Genet       Date:  2012-03-22       Impact factor: 2.103

5.  A pragmatic approach to infants with Robin sequence: a retrospective cohort study and presence of a treatment algorithm.

Authors:  Emma C Paes; Daan P F van Nunen; Lucienne Speleman; Marvick S M Muradin; Bram Smarius; Moshe Kon; Aebele B Mink van der Molen; Aebele B Mink van der Molen; Titia L E M Niers; Esther S Veldhoen; Corstiaan C Breugem
Journal:  Clin Oral Investig       Date:  2015-02-15       Impact factor: 3.573

6.  Recovering Breathing and Feeding of a Newborn with Pierre Robin Sequence.

Authors:  Francisnele Maria de Aquino Fraporti Tomáz; Alvaro Henrique Borges; Alexandre Meireles Borba; Luiz Evaristo Ricci Volpato
Journal:  Ann Maxillofac Surg       Date:  2017 Jan-Jun

7.  Mortality in Robin sequence: identification of risk factors.

Authors:  Robrecht J H Logjes; Maartje Haasnoot; Petra M A Lemmers; Mike F A Nicolaije; Marie-José H van den Boogaard; Aebele B Mink van der Molen; Corstiaan C Breugem
Journal:  Eur J Pediatr       Date:  2018-02-28       Impact factor: 3.183

Review 8.  Growth and prevalence of feeding difficulties in children with Robin sequence: a retrospective cohort study.

Authors:  Emma C Paes; Iris A C de Vries; Wouter M Penris; Karlijn H Hanny; Selma W Lavrijsen; Elselien K van Leerdam; Maaike M Rademaker; Esther S Veldhoen; Rene M J C Eijkemans; Moshe Kon; Corstiaan C Breugem
Journal:  Clin Oral Investig       Date:  2016-11-21       Impact factor: 3.573

9.  Safe sleeping positions: practice and policy for babies with cleft palate.

Authors:  Karen Davies; Iain A Bruce; Patricia Bannister; Peter Callery
Journal:  Eur J Pediatr       Date:  2017-03-22       Impact factor: 3.183

10.  A Retrospective Longitudinal Treatment Review of Multidisciplinary Interventions in Nonsyndromic Robin Sequence With Cleft Palate.

Authors:  Pinelopi K Palaska; Gregory S Antonarakis; Sunjay Suri
Journal:  Cleft Palate Craniofac J       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.